Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWProline-arginine-rich 39 peptide (PR 39 peptide) is an antibacterial peptide.1 It is produced from antibacterial protein PR 39 by extracellular proteases and is primarily expressed by bone marrow-derived immune cells. PR 39 peptide is active against E. coli, S. typhimurium, A. calcoaceticus, B. megaterium, and S. pyogenes (LC50s = 0.3, 1, 3, 0.3, and 2 µM, respectively).2 It inhibits the human 20S proteasome (Ki = 25 nM).3 PR 39 peptide (1 µM) induces calcium-dependent chemotaxis in isolated porcine neutrophils.4 It increases nuclear translocation of hypoxia-inducible factor-1α (HIF-1α) in normoxic- and hypoxic human umbilical vein endothelial cells (HUVECs) when used at a concentration of 5 µM.5 PR 39 induces coronary angiogenesis in mice.
WARNING This product is not for human or veterinary use.
1. Structure of the gene for porcine peptide antibiotic PR-
2. Amino acid sequence of PR-
3. Proline-
4. Chemoattractant properties of PR-
5. PR39, a peptide regulator of angiogenesis. Nat. Med. 6(1), 49-55 (2000).